News

US FDA approves Moderna's new lower-dose Covid-19 vaccine 'mNexspike'
The US approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it not a replacement for ...
Mother Jones3h
The FDA Just Approved a New Covid Vaccine
The Food and Drug Administration (FDA) just green-lit a new Covid vaccine from Moderna, the company said in a press release ...
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
HIV’s Most Promising Breakthrough Has Taken a Hit
Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...
FDA OKs new COVID-19 vaccine for 65 and older, others with conditions
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
BioPharma Dive6h
FDA clears Moderna’s new COVID vaccine, but with limits
The shot, dubbed mNexspike, is approved for older adults and people whose health conditions put them at higher risk of severe ...
Explore more
National Geographic news19d
Moderna’s mRNA vaccine reaches its final phase. Here's how it works.
The surface of the SARS-CoV-2 virus is covered in protein spikes (red). Moderna’s messenger RNA (mRNA) vaccine would teach the human body to recognize these spikes, allowing the body to produce ...
wfft22d
Moderna study shows immune response in older adults for a combo flu and COVID-19 shot
Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 and most strains of flu than existing ...